Add Company
Join Now

Lucence Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Lucence's estimated annual revenue is currently $14.7M per year.(i)
  • Lucence's estimated revenue per employee is $155,000

Employee Data

  • Lucence has 95 Employees.(i)
  • Lucence grew their employee count by -10% last year.

Lucence's People

NameTitleEmail/Phone
1
SVP, US OperationsReveal Email/Phone
2
Clinical Laboratory Scientist III - General supervisorReveal Email/Phone
3
Medical TechnologistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Lucence?

Lucence is an oncologist-founded precision oncology company with the vision of a world without avoidable cancer deaths. The company pioneers ultrasensitive liquid biopsy tests and state-of-the-art data analytics for early cancer detection and treatment selection. Visit www.lucence.com for more information.

keywords:N/A

N/A

Total Funding

95

Number of Employees

$14.7M

Revenue (est)

-10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Lucence News

2022-03-30 - Liquid Biopsy Market 2022 Top Leading Players, Recent Developments, Opportunities, Size, Revenue, Sales, Regional Analysis, Business Strategies, Challenges, Types, Applications

In November 2019, Lucence Diagnostics Pte Ltd, a genomic medicine company based in Singapore, raised US$ 20 Million in Series A funding. In June...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$25.2M959%N/A
#2
$23.3M96-1%N/A
#3
$19.6M968%N/A
#4
N/A9648%N/A
#5
$29.6M9625%N/A